WMSA
MNTA

Weiss Multi-Strategy Advisers’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-121,926
Closed -$6.4M – 851
2020
Q3 		$6.4M Buy
+121,926
New +$5.05M 0.17% 178
2020
Q2 		– Sell
-7,808
Closed -$212K – 640
2020
Q1 		$212K Buy
+7,808
New +$217K 0.01% 386
2014
Q2 		– Sell
-15,030
Closed -$175K – 1006
2014
Q1 		$175K Buy
15,030
+4,440
+42% +$75.2K ﹤0.01% 922
2013
Q4 		$187K Buy
+10,590
New +$178K ﹤0.01% 913

Weiss Multi-Strategy Advisers's MNTA Position: Q4 2020 in Review

Weiss Multi-Strategy Advisers sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 121,926 shares — an estimated $6.4M sold.

Weiss Multi-Strategy Advisers first reported a position in MNTA in Q4 2013 and held it in 4 quarters. The position peaked at $6.4M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Weiss Multi-Strategy Advisers reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 121,926 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $6.4M.
  • Weiss Multi-Strategy Advisers first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2013 and held it in 4 quarters.
  • Weiss Multi-Strategy Advisers's Momenta Pharmaceuticals, Inc. position peaked at $6.4M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.